Article by Emily Laurence, ABC News
An active compound in cannabis plants, once isolated, could be used to treat symptoms of schizophrenia according to findings of a new study.
Researchers at the Illawarra Health and Medical Research Institute (IHMRI) have been investigating what effect Cannabidiol has on the mental illness.
Cognitive and negative symptoms of schizophrenia include social withdrawal and blunted emotional expression.
Previous studies have shown the isolated compound can improve cognition in illnesses like Alzheimer’s disease and stroke.
Using a rodent model of schizophrenia, the research team found cannabidiol was able to restore recognition, working memory and social behaviour.
University of Wollongong PhD candidate Ashleigh Osborne said the findings suggested Cannabidiol could be used as a pharmaceutical drug.